Skip to primary navigation Skip to main content
0 item $0.00

Ms Malancha Karmakar

BSc(Hons) | MSc, University of Calcutta, India

After completion of my master’s degree I worked in industry as a research scientist and was part of a Wellcome Trust funded project, where I led the team responsible for mapping the biochemistry and mechanisms of action of 18 known anti-tuberculosis drugs. This in-silico platform was used to study, design and optimise multi-drug combination therapies, which were validated in vitro and in vivo in partnership with AstraZeneca India R&D.

After working for five years in the industry, I moved on to pursue PhD at the University of Melbourne. My current research focusses on building in-silico tools to identify novel mutations in drugs used for treating tuberculosis. The tools we build can help in selecting appropriate and optimal therapies thereby tailoring medical decisions, interventions and practices based on individual patient. Next, I would like to explore how these structural changes alter the fitness and transmission dynamics, influencing the likelihood of resistance spreading using mathematical models.


  • Major Barlett Travel grant, University of Melbourne (2018)
  • Melbourne International Research Scholarship (2017–2020)
  • Travel grant, Winter School in Mathematical and Computational Biology (2017)


  • Best Student Poster in Basic Science Research, Melbourne Health Research Week, Melbourne University (2018)
  • Best Oral Presentation Award, Department of Biochemistry and Molecular Biology, Melbourne University (2017)
  • Corporate Social Responsibility Award, Bugworks Research, India (2015)
  • Performance Award, Cellworks Research India (2013 and 2014)

Publication highlights

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more